Page last updated: 2024-08-25

rosiglitazone and Liver Dysfunction

rosiglitazone has been researched along with Liver Dysfunction in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (63.64)	29.6817
2010's	4 (36.36)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, J; Chen, Z; Cui, Q; Geng, B; Meng, Y; Wang, J; Yang, J; Yang, W	1
Kavimani, S; Kesavanarayanan, KS; Prathiba, D; Priya, RJ; Selvakkumar, C	1
Chalasani, N; Vuppalanchi, R	1
Jiang, JD; Kong, WJ; Pan, HN; Song, DQ; Wang, SK; Wang, YM; Wang, ZZ; Wei, J; Wu, JD; Xue, R; Zhang, H; Zhao, W; Zhou, ZX	1
Li, LJ; Xu, RL	1
Chen, Y; Jiang, BR; Lu, YL; Qiao, J; Wang, NJ; Yang, LZ; Ye, TT; Yu, J; Zhao, LJ	1
Fackett, A; Hayden, MJ; Hewitt, NJ; Li, AP; Lloyd, S; Sakai, Y; Silber, PM	1
Cutson, JJ; Dietz, KR; Gavrilova, O; Gonzalez, FJ; Haluzik, M; Johnson, L; Matsusue, K; Nicol, CJ; Reitman, ML; Vinson, C	1
Morin-Papunen, LC; Rautio, K; Ruokonen, A; Tapanainen, JS	1
Dülger, GA; Gedik, N; Sehirli, AO; Sener, G	1
Blanchard, J; Eismann, T; Galloway, E; Huber, N; Kuboki, S; Lentsch, AB; Schuster, R; Shin, T; Zingarelli, B	1

Reviews

1 review(s) available for rosiglitazone and Liver Dysfunction

Article	Year
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:1 Topics: Bariatric Surgery; Biomarkers; Biopsy; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Dyslipidemias; Exercise; Fatty Liver; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Liver Cirrhosis; Liver Diseases; Metabolic Syndrome; Metformin; Obesity; Oxidative Stress; Pioglitazone; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones; Weight Loss	2009

Article

Year

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management.

Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:1

Topics: Bariatric Surgery; Biomarkers; Biopsy; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Dyslipidemias; Exercise; Fatty Liver; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Liver Cirrhosis; Liver Diseases; Metabolic Syndrome; Metformin; Obesity; Oxidative Stress; Pioglitazone; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones; Weight Loss

2009

Trials

2 trial(s) available for rosiglitazone and Liver Dysfunction

Article	Year
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism: clinical and experimental, 2010, Volume: 59, Issue:2 Topics: Aged; Berberine; Blood Glucose; Cell Line; Diabetes Mellitus, Type 2; Female; Gene Expression; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Liver Diseases; Male; Metformin; Middle Aged; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, Insulin; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazolidinediones	2010
Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study. Fertility and sterility, 2007, Volume: 87, Issue:1 Topics: Adolescent; Adult; Female; Humans; Hypoglycemic Agents; Inflammation; Liver Diseases; Obesity; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones; Treatment Outcome	2007

Article

Year

Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.

Metabolism: clinical and experimental, 2010, Volume: 59, Issue:2

Topics: Aged; Berberine; Blood Glucose; Cell Line; Diabetes Mellitus, Type 2; Female; Gene Expression; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Liver Diseases; Male; Metformin; Middle Aged; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, Insulin; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazolidinediones

2010

Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study.

Fertility and sterility, 2007, Volume: 87, Issue:1

Topics: Adolescent; Adult; Female; Humans; Hypoglycemic Agents; Inflammation; Liver Diseases; Obesity; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones; Treatment Outcome

2007

Other Studies

8 other study(ies) available for rosiglitazone and Liver Dysfunction

Article	Year
FAM3A mediates PPARγ's protection in liver ischemia-reperfusion injury by activating Akt survival pathway and repressing inflammation and oxidative stress. Oncotarget, 2017, Jul-25, Volume: 8, Issue:30 Topics: Animals; Apoptosis; Cell Survival; Cytokines; Disease Models, Animal; Disease Progression; Gene Expression; Hepatocytes; Liver Diseases; Liver Function Tests; Male; Mice; Mice, Knockout; Oxidative Stress; PPAR gamma; Protein Transport; Proto-Oncogene Proteins c-akt; Reperfusion Injury; Rosiglitazone; Signal Transduction; Thiazolidinediones	2017
Herbal formulation, DIA-2 and Rosiglitazone ameliorates hyperglycemia and hepatic steatosis in type 2 diabetic rats. European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:16 Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diet, High-Fat; Fatty Liver; Hyperglycemia; Hypoglycemic Agents; Liver Diseases; Plant Extracts; Random Allocation; Rats; Rosiglitazone; Thiazolidinediones	2015
[The effect of Rosiglitazone, a PPARgamma receptor agonist, on the NF-kappaB signaling pathway in acute hepatic injury induced by LPS]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:12 Topics: Acute Disease; Animals; Blotting, Western; Disease Models, Animal; I-kappa B Proteins; Injections, Intraperitoneal; Lipopolysaccharides; Liver; Liver Diseases; Male; Mice; NF-kappa B; NF-kappa B p50 Subunit; PPAR gamma; Random Allocation; Rosiglitazone; Signal Transduction; Thiazolidinediones	2009
Rosiglitazone protects diabetic rats from liver destruction. Journal of endocrinological investigation, 2011, Volume: 34, Issue:10 Topics: Animals; Apoptosis; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Fas Ligand Protein; Fatty Liver; In Situ Nick-End Labeling; Liver; Liver Diseases; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rosiglitazone; Thiazolidinediones	2011
Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors. Chemico-biological interactions, 2002, Nov-10, Volume: 142, Issue:1-2 Topics: Adenosine Triphosphate; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Chemical and Drug Induced Liver Injury; Chromans; Coloring Agents; Female; Formazans; Glutathione; Hepatocytes; Humans; Hypoglycemic Agents; Infant; Liver Diseases; Male; Middle Aged; Neutral Red; Oxazines; Rosiglitazone; Sex Factors; Smoking; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Troglitazone; Xanthenes	2002
Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. The Journal of biological chemistry, 2003, Sep-05, Volume: 278, Issue:36 Topics: Adipose Tissue; Animals; Blotting, Southern; Blotting, Western; Female; Hypoglycemia; Insulin Resistance; Lipid Metabolism; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Receptors, Cytoplasmic and Nuclear; Recombination, Genetic; RNA; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Triglycerides	2003
Rosiglitazone, a PPAR-gamma ligand, protects against burn-induced oxidative injury of remote organs. Burns : journal of the International Society for Burn Injuries, 2007, Volume: 33, Issue:5 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Burns; Female; Hypoglycemic Agents; Interleukin-1beta; Kidney Diseases; L-Lactate Dehydrogenase; Liver Diseases; Male; Malondialdehyde; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Urea	2007
Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. Hepatology (Baltimore, Md.), 2008, Volume: 47, Issue:1 Topics: Animals; C-Peptide; E1A-Associated p300 Protein; Gene Expression Regulation; Hepatocytes; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; PPAR gamma; Prostaglandin D2; Reperfusion Injury; Retinoid X Receptor alpha; Rosiglitazone; Thiazolidinediones	2008